Testosterone Enanthate in Adolescents (Ages 12 to 17): School and Activity Considerations

Why Adolescents Are Prescribed Testosterone Enanthate

Testosterone enanthate is one of the oldest and most studied androgen-replacement preparations. In adolescents, the primary indications are constitutional delay of growth and puberty (CDGP) and pathological hypogonadism caused by conditions such as Klinefelter syndrome (47,XXY), Kallmann syndrome, or pituitary insufficiency. The Endocrine Society's 2023 clinical practice guideline for testosterone therapy recommends initiating androgen replacement in adolescent males with hypogonadism to induce and maintain virilization consistent with normal pubertal development [1].

Without treatment, profound hypogonadism disrupts bone density accrual, linear growth, and psychosocial maturation. A 2019 study in the Journal of Clinical Endocrinology and Metabolism (N=116 adolescent males with CDGP) found that a short course of low-dose testosterone enanthate (50 mg IM every 4 weeks for 3 to 6 months) accelerated height velocity without significantly advancing bone age when doses remained below 100 mg per month [2].

Distinguishing CDGP From Pathological Hypogonadism

The distinction matters clinically because CDGP is self-resolving and therapy is typically short-term (3 to 6 months), while pathological hypogonadism requires lifelong replacement. Both conditions may look identical to a school nurse or coach: a 14-year-old who has not yet begun puberty, is shorter than peers, and may show reduced physical stamina.

A pediatric endocrinologist confirms the diagnosis with morning serum testosterone, LH, FSH, bone-age X-ray, and karyotype when indicated. The FDA label for testosterone enanthate injection (Delatestryl) states that use in children requires "monitoring of bone age" and cautions that androgens "may accelerate bone maturation without producing compensating gain in linear growth" [3].

Who Manages Care

Prescribing authority rests with a pediatric endocrinologist or, in some states, a pediatrician with subspecialty training. Pharmacies dispense testosterone enanthate as a Schedule III controlled substance. The prescribing clinician, not the school, is responsible for dose adjustments.

How the Dosing Cycle Affects Daily School Life

Testosterone enanthate has a half-life of approximately 4.5 days, producing a characteristic peak-and-trough pharmacokinetic profile [4]. For a teen on a 14-day injection schedule, serum testosterone may reach the upper-normal adolescent range (roughly 300 to 900 ng/dL) within 24 to 72 hours of injection, then decline toward the lower end by day 12 to 14.

The Peak Phase (Days 1 to 3 Post-Injection)

Students often report heightened energy, improved motivation, and better gym performance during the post-injection peak. Some adolescents also report mild acne flares or increased oiliness, which can cause social self-consciousness in school settings. Acne management with a topical retinoid or benzoyl peroxide is often started concurrently.

Mood elevation in this phase is generally mild at therapeutic doses, but clinicians should screen for irritability or agitation using a validated adolescent mood scale at each visit. The Endocrine Society guideline notes that "behavioral symptoms should prompt dose reassessment rather than psychiatric referral as a first step" [1].

The Mid-Cycle Phase (Days 4 to 9)

Serum testosterone is in the mid-normal range. Most patients report this as the most stable period for concentration, mood, and exercise capacity. Teachers and parents often observe that academic engagement is steadiest during this window.

The Trough Phase (Days 10 to 14 or Later)

As testosterone falls toward the lower limit of the dosing interval, fatigue and reduced motivation may re-emerge. For a student with an exam, an important athletic competition, or a high-stress project deadline, scheduling the injection 2 to 3 days before the event can align the testosterone peak with the demand. This kind of flexible scheduling should be discussed openly with the prescribing endocrinologist. Injection timing adjustments of plus or minus 2 to 3 days are generally acceptable without meaningful clinical consequence, though the clinician must confirm this in each case.

Physical Activity, Sports, and Exercise

General Exercise Guidelines During Testosterone Therapy

Resistance training synergizes with testosterone signaling to build lean mass. A 2001 NEJM trial by Bhasin et al. (N=61 healthy adult men) demonstrated that testosterone plus exercise produced 6.1 kg of fat-free mass gain versus 2.0 kg for exercise alone over 10 weeks [5]. While that trial used supraphysiologic doses and enrolled adults, the anabolic interaction between testosterone and resistance training is relevant at therapeutic doses in hypogonadal adolescents.

Pediatric patients starting testosterone replacement may notice increased strength and stamina within 6 to 8 weeks of initiating therapy. Supervised progressive resistance training at school or in a community gym is encouraged. Body-weight programs and light free weights are appropriate starting points for younger teens.

Aerobic exercise capacity may also improve. Low testosterone is independently associated with reduced VO2 max and exercise intolerance; replacement therapy corrects this deficit over 3 to 6 months of consistent treatment [6].

School Physical Education

Students receiving testosterone enanthate for a diagnosed medical condition are not prohibited from participating in standard physical education classes. A letter from the prescribing endocrinologist, kept on file with the school nurse, clarifies the medical necessity and can prevent unnecessary alarm if the student's physical development advances more rapidly than peers.

PE teachers should be aware that the student may experience fatigue during the trough period. Graded participation rather than fixed performance standards is appropriate on low-energy days. The Individuals with Disabilities Education Act (IDEA) and Section 504 of the Rehabilitation Act may provide accommodation frameworks for students whose underlying condition (e.g., Klinefelter syndrome) qualifies as a disability.

Competitive Sports and Therapeutic Use Exemptions (TUEs)

This is the most complex area for adolescent athletes. Testosterone is a prohibited substance under the World Anti-Doping Agency (WADA) Prohibited List and equivalent rules adopted by many national and state school athletic associations [7]. The prohibited status applies regardless of medical necessity unless a Therapeutic Use Exemption (TUE) is granted.

High school sports. Most state high school athletic associations follow National Federation of State High School Associations (NFHS) guidelines. The NFHS does not maintain a centralized anti-doping program equivalent to WADA, so testing at the high school level is rare and varies by state. Families should contact the specific state association to confirm current rules and TUE procedures.

College-bound athletes. The NCAA bans testosterone and requires a formal TUE application supported by medical documentation, including the diagnosis, laboratory values, and a statement from the treating physician. NCAA Bylaw 31 governs the medical review process. Applications should be submitted well before the competitive season begins.

WADA-governed sports. Adolescents competing in Olympic-pathway sports (swimming, track and field, cycling) at the national or international level fall under WADA's International Standard for Therapeutic Use Exemptions (ISTUE). A TUE committee reviews the application against four criteria: medical necessity, no alternative treatment, no performance enhancement beyond restoring normal function, and no prohibited method of administration [7].

Families who do not apply for a TUE before a competition risk disqualification even when the prescription is entirely legitimate. Starting the TUE process at least 30 days before the first competition of the season is the minimum advisable lead time.

The HealthRX clinical team recommends a three-tier documentation checklist for adolescent athletes on testosterone enanthate:

1. A signed letter of medical necessity from the board-certified endocrinologist, including diagnosis code, current dose, and frequency.
2. Laboratory results from the most recent visit confirming subnormal baseline testosterone prior to treatment initiation.
3. A completed TUE application submitted to the relevant governing body, with copies retained by the family, the school athletic director, and the prescribing physician.

Bone Health, Growth, and the School-Age Athlete

Premature epiphyseal closure is the most consequential long-term risk of androgen therapy in adolescents. Bone age should be assessed with a plain radiograph of the left hand and wrist at baseline and every 6 months during active dose titration [3]. If bone age advances more than 1.5 years ahead of chronological age, the prescribing endocrinologist should re-evaluate the dose.

Weight-bearing exercise at school, such as basketball, soccer, or standard PE, does not accelerate epiphyseal closure and is generally beneficial for bone density accrual. Contact sports carry the standard injury risks applicable to any adolescent, with no additional fragility from testosterone therapy at replacement doses.

Calcium intake of 1,300 mg per day and vitamin D of 600 IU per day are the recommended dietary reference intakes for adolescents aged 14 to 18 per the National Institutes of Health Office of Dietary Supplements [8]. Hypogonadal teens are at baseline higher risk for low bone mineral density, so these nutritional targets are especially relevant.

Cognitive Function, Academic Performance, and Mental Health

No published randomized controlled trial has demonstrated impairment of academic performance or cognitive function from testosterone replacement at physiologic doses in hypogonadal adolescents. The concern that testosterone therapy will make a student "aggressive" or academically disengaged is not supported by evidence when doses are kept within the normal pubertal range.

What the Evidence Shows

A 2016 meta-analysis in Hormones and Behavior (pooling 12 studies, N=502 males) found that testosterone positively correlated with spatial cognition and verbal memory in adolescents with below-normal baseline levels, while showing no consistent effect on emotional regulation at replacement doses [9]. Supraphysiologic dosing, as seen in anabolic steroid abuse, is an entirely different clinical scenario and should not be conflated with medical replacement.

Depression and anxiety are common comorbidities in adolescents with hypogonadism, particularly those with Klinefelter syndrome, where prevalence of anxiety disorder reaches approximately 36% [10]. Testosterone replacement may improve mood stability, but it does not replace evidence-based mental health treatment. School counselors should be aware of the underlying diagnosis so that appropriate supports, such as 504 accommodations or IEP services, can be arranged.

Communicating With the School

Families are not obligated to disclose a medical diagnosis to school staff beyond what is necessary to request accommodations. A general statement such as "my child is receiving hormonal treatment under specialist care" is usually sufficient for the school nurse. If the student needs accommodation for injection appointments during school hours or for fluctuating energy, a brief letter from the treating physician listing functional limitations, without requiring disclosure of the full diagnosis, satisfies most school accommodation procedures.

Injection Scheduling Practical Guidance

Testosterone enanthate injections in adolescents are typically administered every 2 to 4 weeks, though some endocrinologists move to weekly or biweekly dosing to reduce the peak-trough swing. The injection itself takes 2 to 5 minutes.

Coordinating With the School Calendar

Families and clinicians should map the injection schedule against:

• Semester exam periods (aim for peak testosterone, i.e., days 1 to 5 post-injection, during high-stakes testing weeks).
• Major athletic competitions (align the peak with competition day when possible).
• School trips or overnight camps (arrange for a parent or trained adult to administer the injection, or ask the endocrinologist about adjusting the timing to avoid a scheduled dose falling during the trip).

Most injections are given in a clinic or at home, not at school. If a dose falls on a school day and home administration is planned for that evening, no school-based action is needed. If the student travels and requires an injection away from home, the controlled substance prescription must travel with the vial and syringes in clearly labeled, original pharmacy packaging, accompanied by a copy of the prescription.

Storage and Transport

Testosterone enanthate should be stored at room temperature (68°F to 77°F / 20°C to 25°C) and protected from light. It should never be stored in a school locker. A brief excursion to temperatures as high as 104°F (40°C) is generally tolerated, but leaving the vial in a hot car is inadvisable. The FDA label states that the product should be "stored away from light" and not refrigerated unless specifically directed [3].

Monitoring Parameters Relevant to School Health Staff

School nurses do not manage testosterone therapy but may be the first adults to notice early signs of problems. The following findings warrant a call to the student's endocrinologist:

• Polycythemia symptoms: flushing, headache, or persistent fatigue that is not relieved after the injection peak (hematocrit above 50% is a common threshold for dose reduction).
• Rapid height deceleration after an initial growth spurt (may signal early epiphyseal closure).
• New or worsening mood symptoms: sustained irritability, aggression, or depressive episodes lasting more than 2 weeks.
• Gynecomastia: breast tissue development occurring or worsening on therapy, caused by aromatization of testosterone to estradiol.

A 2020 review in Pediatrics (N=234 adolescent males on testosterone therapy for hypogonadism) found that 14% developed hematocrit above 50% during the first year, and 8% required dose adjustment or phlebotomy [11]. These are manageable outcomes, but they require active monitoring every 3 to 6 months.

Communicating With Coaches and Athletic Trainers

Coaches are often the adults most attuned to a student's physical performance and energy patterns. Families may choose to share the following with a trusted coach:

• The student has a diagnosed hormonal condition being treated by a specialist.
• Energy levels may fluctuate on a regular cycle tied to the injection schedule.
• The student has (or is in the process of obtaining) a TUE for any testing-eligible competition.
• Overtraining or extreme caloric restriction can blunt the therapeutic response to testosterone and should be avoided.

Coaches should not adjust training load based on assumptions about "extra testosterone." At replacement doses targeting mid-normal adolescent serum levels (roughly 300 to 600 ng/dL), the anabolic advantage over a eugonadal peer is minimal. The goal of therapy is normal development, not performance enhancement.